T1	intervention 81 92	ropivacaine
T2	condition 134 160	chronic postoperative pain
T3	No-of-participants 551 554	236
T4	control 648 655	placebo
T5	outcome-Measure 770 780	Acute pain
T6	outcome-Measure 782 803	analgesic consumption
T7	outcome-Measure 805 811	nausea
T8	outcome-Measure 816 824	vomiting
T9	outcome 1150 1168	postoperative pain
T10	outcome 1313 1338	incidence of chronic pain
T11	intervention-value 1343 1346	33%
T12	control-value 1351 1354	27%
T13	outcome 1437 1488	brief pain inventory, neuropathic pain, and anxiety
T14	outcome 1573 1586	complications
